You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Anti-hIAPP for the preservation of pancreatic function in Type 2 Diabetes
SBC: CELDARA MEDICAL, LLC Topic: 200Project Summary According to the American Diabetes Association, Type 2 diabetes mellitus (T2D) affects at least 30 million Americans and is a major unmet public health concern with an annual cost in the United States of over $300 billion dollars. Additionally, nearly 25% of the U.S. population is already considered prediabetic, or at high risk of developing T2D. These individuals are characterized ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Non-invasively extendable megaprosthesis
SBC: Granite Medical, LLC Topic: NIAMSABSTRACT This project is the development of a non-invasively extending distal femur replacement (DFR) for children and adolescents subsequent to bone tumor resection. Each year in the US there are 200-250 malignant bone tumor diagnoses in the distal femurs of patients 15 years and younger. With advances in chemotherapy, limb salvage surgery utilizing a megaprosthesis has increasingly become the tr ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
SBC: CELDARA MEDICAL, LLC Topic: 105SUMMARY Amyotrophic lateral sclerosis (ALS) patients develop fatal paralysis as a result of progressive motor neuron loss in the brain and spinal cord. There are more than 5,000 new cases of ALS per year in the United States, with typical age of onset between 40 and 70 years of age. While SOD1 is a cytoplasmic protein, misfolded SOD1 can be secreted and form extracellular oligomers and aggregates. ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Ultrasound-coupled Electrical Impedance Tomography for Sarcopenia Assessment
SBC: RYTEK MEDICAL INC Topic: NIAPROJECT SUMMARY/ABSTRACT Clinical Need: The coming decades promise a revolution in the personalized treatment for patients with breast cancer, including approaches to minimize collateral damage of curative. However, to help facilitate this, the academic and industrial clinical research communities need improved diagnostic biomarkers to assess the presence of muscle diseases such as sarcopenia. Onc ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
04b Quick-Turn Spaceborne Printed Circuit Boards
SBC: MICRO-PRECISION TECHNOLOGIES, INC. Topic: C5404bThere is no manufacturing solution available today that can achieve quick-turn production of spaceborne printed circuit boards while adhering to the rigidity requirements of industry standards and surviving the rigors of space launch and flight. To fulfill the production needs of the defense and aerospace industries, this program will develop an additive manufacturing process combining the ruggedn ...
SBIR Phase II 2023 Department of Energy -
Preclinical development of an important, broad-spectrum antibody for pandemic influenza
SBC: CELDARA MEDICAL, LLC Topic: NIAIDHealth and human services (HHS) and the Biomedical Advanced Research and Development Authority (BARDA) have suggested a severe pandemic influenza outbreak is the greatest current threat to national and global security. The Center for Disease Control rates H7N9 as the most threatening of the Influenza A viruses as it, along with H5N1, have fatality rates of ~40% and ~60%, respectively. Models have ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Control of Grain Properties and Slug Geometry for High-Performance Metallic Fuel
SBC: CREARE LLC Topic: C5640vC56-40v-272647Next-generation nuclear power plants can provide a large-scale source of environmentally benign power generation while improving safety and minimizing proliferation risks. For best performance, these reactors will require large numbers of uranium alloy fuel slugs produced with metallurgical properties that enable reliable, long-term operation. No method currently exists for high-volu ...
SBIR Phase I 2023 Department of Energy -
Crack Prevention and Mitigation for New and In-Service Dry Storage Canisters
SBC: CREARE LLC Topic: C5641bC56-41b-273026Welded stainless steel canisters at near-marine sites that contain spent nuclear fuel (SNF) have been found with salts on their outer surface that can produce an aggressive chemical environment. These conditions could lead to pitting, stress corrosion cracking (SCC), and potential release of radioactive materials. We propose to develop an innovative process and device for mitigating ...
SBIR Phase I 2023 Department of Energy -
A Rugged, Reliable, Portable, Safe, and Simple Naloxone HCl Auto-Injector forLife-Saving Treatment of Opioid Overdose
SBC: PIROUETTE MEDICAL, INC. Topic: NIDAProject Summary From 2019 to 2020, overdose deaths in the US increased by 30% year on year; 187 people die each day from opioid overdose in the US. Naloxone has significantly decreased opioid mortality with increased usage as a first line life-saving measure prior to emergency help and hospitalization. Naloxone HCl Injection, USP (Naloxone) is an opioid antagonist that rapidly reverses overdose an ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Kv2.1-Targeted First in Class Neuroprotective Therapeutic for Acute Ischemic Stroke
SBC: CELDARA MEDICAL, LLC Topic: 105Project Summary Acute ischemic stroke (AIS) impacts 795,000 Americans per year, leaving 90% of patients with chronic disability. Prevalent cases of AIS in the US were estimated at 6.7M in 2017, translating to 6M Americans living with permanent stroke-related disability. AIS is characterized by cerebrovascular blockage that results in the formation of a central infarct with a surrounding ischemic p ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health